Sara Malo Fumanal, Professor of Public Health at the University of Zaragoza and Researcher at the IIS Aragón, talks in this article from The Conversation about society's use of medicines.
Analysis of brain activity and a specific marker in the blood can help detect these early alterations in individuals without symptoms. The study included 76 participants without cognitive impairment, of whom 54 had a family history of the disease.